{"id":"https://openalex.org/W2105800639","doi":"https://doi.org/10.2174/1574891x10666150415120506","title":"Cancer Targeted Magic Bullets for Effective Treatment of Cancer","display_name":"Cancer Targeted Magic Bullets for Effective Treatment of Cancer","alternate_titles":[],"publication_year":2015,"publication_date":"2015-05-12","ids":{"openalex":"https://openalex.org/W2105800639","doi":"https://doi.org/10.2174/1574891x10666150415120506","mag":"2105800639","pmid":"https://pubmed.ncbi.nlm.nih.gov/25876849"},"language":"en","primary_location":{"id":"doi:10.2174/1574891x10666150415120506","doi":"https://doi.org/10.2174/1574891x10666150415120506","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1574891x10666150415120506","pdf_url":null,"source":{"id":"https://openalex.org/S117972718","display_name":"Recent Patents on Anti-Infective Drug Discovery","issn_l":"1574-891X","issn":["1574-891X","2212-4071"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-40"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Recent Patents on Anti-Infective Drug Discovery","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2105800639"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021959219","display_name":"Preeti Aneja","orcid":"https://orcid.org/0000-0002-7109-285X","observed_orcids":["https://orcid.org/0000-0002-7109-285X"]},"institutions":[{"id":"https://openalex.org/I4405260938","display_name":"Abhilashi University","ror":"https://ror.org/04gs3ey40","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405260938"]}],"countries":["IN"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Preeti Aneja","raw_affiliation_strings":["Abhilashi College of Pharmacy, Tanda, Ner Chowk, Mandi, Himachal Pradesh, India-175008. preetianeja08@gmail.com",",India","Abhilashi College of Pharmacy, Tanda, Ner Chowk, Mandi, Himachal Pradesh, India-175008"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abhilashi College of Pharmacy, Tanda, Ner Chowk, Mandi, Himachal Pradesh, India-175008. preetianeja08@gmail.com","institution_ids":["https://openalex.org/I4405260938"]},{"raw_affiliation_string":",India","institution_ids":[]},{"raw_affiliation_string":"Abhilashi College of Pharmacy, Tanda, Ner Chowk, Mandi, Himachal Pradesh, India-175008","institution_ids":["https://openalex.org/I4405260938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041945418","display_name":"Mahfoozur Rahman","orcid":"https://orcid.org/0000-0002-5616-4026","observed_orcids":["https://orcid.org/0000-0002-5616-4026"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mahfoozur Rahman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028490369","display_name":"Sarwar Beg","orcid":"https://orcid.org/0000-0002-3304-2712","observed_orcids":["https://orcid.org/0000-0002-3304-2712"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sarwar Beg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002633452","display_name":"Shivali Aneja","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405260938","display_name":"Abhilashi University","ror":"https://ror.org/04gs3ey40","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405260938"]}],"countries":["IN"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Shivali Aneja","raw_affiliation_strings":[",India","Abhilashi College of Pharmacy, Tanda, Ner Chowk, Mandi, Himachal Pradesh, India-175008"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":",India","institution_ids":[]},{"raw_affiliation_string":"Abhilashi College of Pharmacy, Tanda, Ner Chowk, Mandi, Himachal Pradesh, India-175008","institution_ids":["https://openalex.org/I4405260938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027097111","display_name":"Vishal Dhingra","orcid":"https://orcid.org/0000-0002-0097-8178","observed_orcids":["https://orcid.org/0000-0002-0097-8178"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vishal Dhingra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027024027","display_name":"Rupali Chugh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rupali Chugh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5002633452","https://openalex.org/A5021959219"],"corresponding_institution_ids":["https://openalex.org/I4405260938"],"apc_list":null,"apc_paid":null,"fwci":0.4735,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.49044427,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"9","issue":"2","first_page":"121","last_page":"135"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13202","display_name":"Pharmacology and Nanomedicine Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-nanomedicine","display_name":"cancer nanomedicine","score":0.9070000052452087},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.8880000114440918},{"id":"https://openalex.org/keywords/nanocarriers","display_name":"nanocarriers","score":0.8370000123977661},{"id":"https://openalex.org/keywords/surface-modification","display_name":"surface modification","score":0.5389999747276306},{"id":"https://openalex.org/keywords/active-targeting","display_name":"active targeting","score":0.9079999923706055},{"id":"https://openalex.org/keywords/passive-targeting","display_name":"passive targeting","score":0.9940000176429749},{"id":"https://openalex.org/keywords/magnetic-targeting","display_name":"magnetic targeting","score":0.972000002861023},{"id":"https://openalex.org/keywords/cancer-theranostics","display_name":"cancer theranostics","score":0.6420000195503235},{"id":"https://openalex.org/keywords/in-vivo-imaging","display_name":"in vivo imaging","score":0.5830000042915344},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5849999785423279},{"id":"https://openalex.org/keywords/nanomedicine-regulation","display_name":"nanomedicine regulation","score":0.5799999833106995},{"id":"https://openalex.org/keywords/clinical-translation","display_name":"clinical translation","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C18150654","wikidata":"https://www.wikidata.org/wiki/Q17153796","display_name":"Nanocarriers","level":3,"score":0.8471670150756836},{"id":"https://openalex.org/C2992152733","wikidata":"https://www.wikidata.org/wiki/Q6730904","display_name":"Magic bullet","level":2,"score":0.6663755178451538},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.580910325050354},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5311827659606934},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.510989785194397},{"id":"https://openalex.org/C126511603","wikidata":"https://www.wikidata.org/wiki/Q1261145","display_name":"Targeted drug delivery","level":3,"score":0.502476692199707},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4686766266822815},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.45078057050704956},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3877933621406555},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2596476078033447},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.20485252141952515},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07582524418830872},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07488617300987244}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010330","descriptor_name":"Patents as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D036103","descriptor_name":"Nanotechnology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2174/1574891x10666150415120506","doi":"https://doi.org/10.2174/1574891x10666150415120506","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1574891x10666150415120506","pdf_url":null,"source":{"id":"https://openalex.org/S117972718","display_name":"Recent Patents on Anti-Infective Drug Discovery","issn_l":"1574-891X","issn":["1574-891X","2212-4071"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-40"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Recent Patents on Anti-Infective Drug Discovery","raw_type":"journal-article"},{"id":"pmid:25876849","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25876849","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Recent patents on anti-infective drug discovery","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.979200005531311,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3009307239","https://openalex.org/W3169606783","https://openalex.org/W3100417590","https://openalex.org/W4361832434","https://openalex.org/W4319459001","https://openalex.org/W7141112726","https://openalex.org/W4223919068","https://openalex.org/W7223185841","https://openalex.org/W3010902082","https://openalex.org/W2773347753"],"abstract_inverted_index":{"Cancer":[0],"is":[1,105],"a":[2,24,172,242],"multifaceted":[3],"disorder":[4],"with":[5],"serious":[6],"threat":[7],"across":[8],"the":[9,33,54,74,81,98,103,109,126,169,179,201,207,218,226,232,234,249],"globe.":[10],"The":[11,134],"vision":[12],"for":[13,19,40,92,149,209,225,241],"accomplishing":[14],"an":[15,87,140],"effective":[16,88,117],"treatment":[17,41,93,170,210],"strategy":[18],"cancer":[20,127],"has":[21],"always":[22],"been":[23,84,189],"major":[25],"concern":[26],"worldwide.":[27],"Although":[28],"conventional":[29],"drug":[30,118,145,185],"therapy,":[31],"esp.":[32],"chemotherapeutics":[34],"provide":[35,116,139],"benefits":[36],"upto":[37],"certain":[38],"extent":[39],"and":[42,58,70,89,160,195,220],"management":[43],"of":[44,53,62,94,100,125,171,175,204,206,211,228,247],"cancers,":[45],"yet":[46],"it":[47],"possesses":[48],"umpteen":[49],"challenges":[50],"in":[51,130,168,244],"terms":[52],"associated":[55],"side":[56],"effects":[57],"adverse":[59],"effects,":[60],"lack":[61],"targeting":[63,146,159],"ability,":[64],"multi-drug":[65],"resistance,":[66],"poor":[67],"patient":[68],"acceptance":[69,205],"compliance,":[71],"etc.":[72],"at":[73],"desired":[75],"site.":[76],"To":[77],"overcome":[78],"these":[79],"problems,":[80],"nanomedicines":[82,150,208],"have":[83,188],"evolved":[85],"as":[86],"cost-effectual":[90],"alternative":[91],"cancer.":[95,176],"Inspiring":[96],"from":[97],"concept":[99],"magic":[101],"bullet,":[102],"world":[104],"moving":[106],"towards":[107],"developing":[108,248],"surface":[110],"modified":[111],"nanocarriers,":[112],"which":[113],"not":[114],"only":[115],"delivery":[119,186],"but":[120],"also":[121],"allows":[122],"site-specific":[123],"monitoring":[124],"cells":[128],"through":[129],"vivo":[131],"diagnostic":[132],"imaging.":[133],"present":[135],"review":[136],"endeavors":[137],"to":[138,178,238],"explicit":[141],"account":[142],"on":[143],"various":[144],"strategies":[147],"employed":[148],"like":[151],"active":[152],"targeting,":[153,155,157,162],"passive":[154],"magnetic":[156],"physical":[158],"ultrasound":[161],"etc,":[163],"followed":[164],"by":[165,191],"their":[166],"utility":[167],"particular":[173],"type":[174],"According":[177],"recent":[180],"market":[181],"survey,":[182],"many":[183,214],"nanocarrier-based":[184],"systems":[187],"approved":[190],"USFDA,":[192],"EMEA,":[193],"MHRA":[194],"other":[196],"global":[197],"regulatory":[198],"agencies,":[199],"testify":[200],"high":[202],"degrees":[203],"cancer,":[212],"while":[213],"products":[215],"are":[216],"under":[217],"preclinical":[219],"clinical":[221],"development":[222],"phases.":[223],"Thus,":[224],"translation":[227],"such":[229],"technologies":[230],"into":[231],"clinic,":[233],"pharma":[235],"industry":[236],"needs":[237],"be":[239],"metamorphosing":[240],"change":[243],"its":[245],"culture":[246],"traditional":[250],"therapeutics.":[251]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2105800639","counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
